SARS-CoV-2 spike antibody concentration in gamma globulin products from high-prevalence COVID-19 countries are transmitted to X-linked agammaglobulinemia patients

PurposePatients with X-linked agammaglobulinemia (XLA) are characterized by humoral impairment and are routinely treated with intravenous immunoglobulin (IVIG). In this study, we aimed to investigate the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in IVIG prep...

詳細記述

書誌詳細

主要な著者:	Allon Raphael, Oded Shamriz, Ariella Tvito, Sophie Magen, Shmuel Goldberg, Orli Megged, Atar Lev, Amos J. Simon, Yuval Tal, Raz Somech, Rachel Eisenberg, Ori Toker
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2023-03-01
シリーズ:	Frontiers in Immunology
主題:	COVID-19 immunodeficiency IVIg antibodies XLA
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1156823/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!